Akdeniz F, Vahip S, Pirildar S, Vahip I, Doganer I, Bulut I. (2003). Risk factors associated with childbearing-related episodes in women with bipolar disorder. Psychopathology. 36 (5):234- 238. https://doi.org/10.1159/000073448
Andrade C. (2022). Gestational Exposure to Antidepressant Drugs and Neurodevelopment: An Examination of Language, Mathematics, Intelligence, and Other Cognitive Outcomes. The Journal of Clinical Psychiatry. 25;83(1):22f14388. https://doi.org/10.4088/JCP.22f14388
Ayers S, Bond R, Webb R, Miller P, Bateson K. (2019). Perinatal mental health and risk of child maltreatment: A systematic review and meta-analysis. Child abuse and neglect. 98:104172. https://doi.org/10.1016/j.chiabu.2019.104172
Babu GN, Desai G, & Chandra PS. (2015). Antipsychotics in pregnancy and lactation. Indian Journal of Psychiatry. 57(Suppl 2): S303–S307. https://doi.org/10.4103/0019-5545.161497
Bakker MK, Jentink J, Vroom F, Van Den Berg PB, De Walle HEK, De Jong-Van Den Berg LTW. (2006). Drug prescription patterns before, during and after pregnancy for chronic, occasional and pregnancy-related drugs in the Netherlands. BJOG. 113:559–568. https://doi.org/10.1111/j.1471-0528.2006.00927.x
Batt MM, Olsavsky AK, Dardar S, John-Larkin CSt, Johnson RL, Sammel MD. (2022). Course of Illness and Treatment Updates for Bipolar Disorder in the Perinatal Period. Current Psychiatry reports. 24(2):111-120. https://doi.org/ 10.1007/s11920- 022-01323-6
Bishop DVM. (2010). Which Neurodevelopmental Disorders Get Researched and Why. PLoS ONE. 5(11): e15112. https://doi.org/10.1371/journal.pone.0015112
Clark CT. (2020). Psychotropic drug use in perinatal women with bipolar disorder. Seminars in Perinatology. 44(3):151230. https://doi.org/10.1016/j.semperi.2020.151230
Delarue-Hurault C., Damase-Michel C., Finitto L., Guitard C, Vayssière C, Montastruc JL, Montastruc F, Lacroix I. (2016). Psychomotor developmental effects of prenatal exposure to psychotropic drugs: a study in EFEMERIS database. Clinical Pharmacology. 30(5):476-82. https://doi.org/10.1111/fcp.12209
Edinoff A.N., Sathivadivel N., McNeil S.E., Ly A.I., Kweon J., Kelkar N., Cornett E.M., Kaye A.M., Kaye A.D. (2022). Antipsychotic Use in Pregnancy: Patient Mental Health Challenges, Teratogenicity, Pregnancy Complications and Postnatal Risks. Neurology International. 14 (1):62–74. https://doi.org/10.3390/neurolint14010005
Egger M, Smith GD, Schneider M, Minder C. (1997). Bias in Meta-Analysis Detected by a Simple, Graphical Test. BMJ, 315, 629–634. https://doi.org/10.1136/bmj.315.7109.629
Fatima Z, Zahra A, Ghouse M, Wang X, Yuan Z. (2018). Maternal SSRIs experience and risk of ASD in offspring: a review. Toxicology Research. 11;7(6):1020-1028. https://doi.org/10.1039/c8tx00102b
FDA Content and Format of Labeling for Human Prescription Drug and Biological Products. Requirements for Pregnancy and Lactation Labeling. (2014)
Hálfdánarson Ó, Cohen JM, Karlstad Ø, Cesta CE, Bjørk MH, Håberg SE, Einarsdóttir K, Furu K, Gissler M, Hjellvik V, Kieler H, K Leinonen M, Nørgaard M, Essen BÖ, Ulrichsen SP, Reutfors J, Zoega H. (2022). Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study. Evidence-Based Mental Health. 25(2):54-62. https://doi.org/ 10.1136/ebmental-2021-300311
Hanley GE & Mintzes B. (2014). Patterns of psychotropic medicine use in pregnancy in the United States from 2006 to 2011 among women with private insurance, BMC Pregnancy Childbirth. 14:242. https://doi.org/ 10.1186/1471-2393-14-242
Higgins, J.P.T. (2003). Measuring Inconsistency in Meta-Analyses. BMJ. 327, 557–560. https://doi.org/10.1136/bmj.327.7414.557
Houben E, te Winkel B, Steegers EAP, Herings RMC (2020). Dutch trends in the use of potentially harmful medication during pregnancy, British Journal of Clinical Pharmacology. 86(12):2377–2392. https://doi.org/10.1111/bcp.14341
Howard LM & Khalifeh H. (2020). Perinatal mental health: a review of progress and challenges. World Psychiatry. 19(3):313-327. https://doi.org/ 10.1002/wps.20769
Janecka M., Kodesh A., Levine S.Z., Lusskin S.I., Viktorin A, Rahman R, Buxbaum JD, Schlessinger A, Sandin S, Reichenberg A. (2018). Association of Autism Spectrum Disorder with Prenatal exposure to Medication Affecting Neurotransmitter Systems. JAMA Psychiatry. 75(12):1217-1224. https://doi.org/10.1001/jamapsychiatry.2018.2728
Johnson KC, LaPrairie JL, Brennan PA, Stowe ZN, Newport DJ. (2012). Prenatal antipsychotic exposure and Neuromotor performance during infancy. Archives Of General Psychiatry. 69(8):787-794. https://doi.org/10.1001/archgenpsychiatry.2012.160
Jordan S, Bromley R, Damase-Michel C, Given J, Komnimou S, Loane M, Marfell N, Dolk H. (2022). Breastfeeding, pregnancy, medicines, neurodevelopment, and population databases: the information desert. International Breastfeeding Journal. 17:55. https://doi.org/10.1186/s13006-022-00494-5
Knight M, Bunch K, Tuffnell D, Patel R, Shakespeare J, Kotnis R, Kenyon S, Kurinczuk JJ (Eds.) on behalf of MBRRACE-UK. (2021). Saving Lives, Improving Mothers’ Care - Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2017-19. Oxford: National Perinatal Epidemiology Unit, University of Oxford
Leek JC & Arif H. (2023). Pregnancy Medications. StatPearls Publishing LLC
Liew Z, Meng Q, Yan Q, Schullehner J, Hansen B, Kristiansen SM, Voutchova DD, Olsen J, Ersbøll AK, Ketzel M, Raaschou-Nielsen O, Ritz BR. (2023). Association Between Estimated Geocoded Residential Maternal Exposure to Lithium in Drinking Water and Risk for Autism Spectrum Disorder in Offspring in Denmark. JAMA Pediatrics. 1;177(6):617-624. https://doi.org/10.1001/jamapediatrics.2023.0346
Menon SJ. (2008). Psychotropic medication during pregnancy and lactation. Archives of Gynecology and Obstetrics. 277(1):1-13. https://doi.org/10.1007/s00404-007-0433-2
Mughal S., Azhar Y. & Siddiqui W. (2022). Postpartum Depression. StatPearls Publishing LLC
O’Hara MW & Wisner KL. (2014). Perinatal mental illness: definition, description and aetiology. Gynaecology. 28(1):3- 12. https://doi.org/10.1016/j.bpobgyn.2013.09.002
Peng M, Gao K, Ding Y, Ou J, Calabrese JR, Wu R, Zhao J. (2013). Effects of prenatal exposure to atypical antipsychotics on postnatal development and growth of infants: A case-controlled, prospective study. Psychopharmacology. 228:577–584. https://doi.org/ 10.1007/s00213-013-3060-6
Pernia S & DeMaagd G. (2016). The New Pregnancy and Lactation Labeling Rule. Pharmacy and Therapeutics, 41(11): 713–715
Petersen I, Sammon CJ, McCrea RL, Osborn DPJ, Evans SJ, Cowen PJ, Nazareth I. (2016). Risks associated with antipsychotic treatment in pregnancy: Comparative cohort studies based on electronic health records. Schizophrenia Research. 176(2-3):349-356. https://doi.org/10.1016/j.schres.2016.07.023
Poels EMP, Bijma HH, Galbally M, Bergink V. (2018). Lithium during pregnancy and after delivery: a review. International journal of bipolar disorders. 2;6(1):26. https://doi.org/10.1186/s40345-018-0135-7
Schmied V, Johnson M, Naidoo N, Austin MP, Matthey S, Kemp L, Mills A, Meade T, Yeo A. (2013). Maternal mental health in Australia and New Zealand: A review of longitudinal studies, Women and Birth, 26(3):167-178. https://doi.org/10.1016/j.wombi.2013.02.006
Schrijver L, Robakis KT, Kamperman AM, Bijma H, Honig A, L van Kamp I, Hoogendijk WJG, Bergink V, Poels EM. (2023). Neurodevelopment in school-aged children after intrauterine exposure to antipsychotics. Acta Psychiatrica Scandinavica. 147(1):43-53. https://doi.org/10.1111/acps.13517
Shao P, Ou J, Peng M, Zhao J, Chen J, Wu R. (2015). Effects of Clozapine and other Atypical Antipsychotics on Infants Development Who Were Exposed to as Fetus: A Post-hoc Analysis. PLOS ONE. 10(4): e0123373. https://doi.org/ 10.1371
Slone D, Siskind V, Heinonen OP, Monson RR, Kaufman DW, Shapiro S. (1997). Antenatal exposure to the phenothiazines in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. American Journal of Obstetrics Gynecology. 128(5):486-488. https://doi.org/10.1016/0002-9378(77)90029-1/journal.pone.0123373
Solari H, Dickson KE, Miller L. (2009). Understanding and treating women with schizophrenia during pregnancy and postpartum, Canadian Journal of Clinical Pharmacology. 16(1): e23-e23
Stika L, Elisova K, Honzáková L, Hrochová H, Plechatová H, Strnadová J, Skop B, Svihovec J, Váchova M, Vinar O. (1990). Effects of drug administration in pregnancy on children’s school behavior. Pharmaceutisch Weekblad Scientific. 12(6):252-5. https://doi.org/ 10.1007/BF01972906
Straub L, Hernández-Diaz S, Bateman BT, Wisner KL, Gray KJ, Pennell PB, Lester B, McDougle CJ, Suarez EA, Zhu Y, Zakoul H, Mogun H, Huybrechts KF. (2022). Association of Antipsychotic Drug Exposure in Pregnancy with risk of Neurodevelopmental Disorders. JAMA Internal Medicine. 1;182(5):522-533. https://doi.org/ 10.1001/jamainternmed.2022.0375
Ta-Chuan Y, Ya-Mei B, Hsu JW, Huang KL, Shih-Jen T, Hsuan-Te C, Chih-Sung L, Mu-Hong C, Chen MH. (2021). Bipolar women’s antepartum psychotropic exposure and offspring risk of attention deficit/hyperactivity disorder and autism spectrum disorder. Journal of Affective Disorders. 295:1407-1414. https://doi.org/10.1016/j.jad.2021.09.016
Tosato S, Albert U, Tomassi S, Iasevoli F, Carmassi C, Ferrari S, Nanni MG, Nivoli A, Volpe U, Atti AR, Fiorillo A. (2017). A Systematized Review of Atypical Antipsychotics in Pregnant Women, The Journal of Clinical Psychiatry. 78(5):e477-e489. https://doi.org/10.4088/JCP.15r10483
Wallace BC, Schmid CH, Lau J, Trikalinos TA. (2009). Meta-Analyst: Software for Meta-Analysis of Binary, Continuous and Diagnostic Data. BMC Medical Research Methodology. 9:80. https://doi.org/10.1186/1471-2288-9-80
Wang Z, Chan AYL, Coghill D, Ip P, Lau WCY, Simonoff E, Brauer R, Wei L, Wong ICK, Man KKC. (2021). Association between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity disorder, Preterm Birth, and Small for Gestational Age. Jama Internal Medicine. 181(10), 1332-1340. https://doi.org/10.1001/jamainternmed.2021.4571
Wibroe MA, Mathiasen R, Pagsberg AK, Uldall P. (2017). Risk of impaired cognition after prenatal exposure to psychotropic drugs. Acta Psychiatrica Scandinavica. 136(2):177-187. https://doi.org/10.1111/acps.12754
Wichman CL. (2009). Atypical antipsychotic use in pregnancy: a retrospective review. Archives of Women’s Mental Health. 12:53–57. https://doi.org/ 10.1007/s00737-008-0044-3